Abstract
To investigate the mechanisms of anaphylactoid reactions to radiocontrast media, in vitro mediator release induced by three iodinated contrast agents was examined using peripheral blood basophils and mast cells purified from human lung parenchyma, heart, and skin tissues. Three iodinated contrast agents, sodium and meglumine salts of ioxaglic acid, sodium and meglumine salts of ioxithalamic acid, and ioversol, were incubated with basophils purified from peripheral blood and human mast cells isolated and purified from different anatomical sites. Release of preformed (histamine and tryptase) and de novo synthesized mediators (prostaglandin D2 and leukotriene C4) into the supernatans was determined at various contrast medium concentrations after incubation for 60 min. Ioxaglate (0.2–0.3 M), ioxithalamate (0.3–0.5 M), and to a lesser extent ioversol (0.3–0.5 M) induced histamine release from basophils in a concentration-dependent manner. All three induced the release of preformed mediators (histamine and tryptase) from human lung, but not from skin mast cells. They also induced histamine and tryptase release from human heart mast cells. However, they did not induce the de novo synthesis of leukotriene C4 or prostaglandin D2 from human basophils or any type of mast cell examined. Cross-linking of IgE by anti-IgE induced the release of leukotriene C4 or prostaglandin D2 from human basophils or mast cells. Mannitol, an osmotic stimulus, induced the release of histamine from human basophils, but to a lesser extent from mast cells. These results show that different contrast media can differ in their ability to release mediators from enriched preparations of human basophils and mast cells. The three contrast agents examined act on basophils and mast cells as incomplete secretagogues, causing the release of preformed mediators, but not the de novo synthesis of chemical mediators. It may be useful to measure plasma tryptase levels to detect adverse reactions caused by iodinated radiographic contrast materials.
Similar content being viewed by others
References
Thomas WM. X-ray contrast media: where are we now, and where are we going? Radiology 1993; 188: 11.
Sovak M. Contrast media: a journey almost sentimental. Invest Radiol 1994; 29 [Suppl 1]: S4.
Bielory L, Kaliner MA. Anaphylactoid reactions to radiocontrast material. Int Anesthesiol Clin 1985; 3: 97.
Erffmeyer JE, Siegle RL, Lieberman P. Anaphylactoid reactions to radiocontrast material. J Allergy Clin Immunol 1985; 75: 401.
Lieberman P. Anaphylactoid reactions to radiocontrast material. Immunol Allergy Clin North Am 1992; 3: 649.
Palmer FJ. The RACR survey of intravenous contrast media reactions. Final report. Australas Radiol 1988; 32: 426.
Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from Japanese committee on the safety of contrast media. Radiology 1990; 175: 621.
Heyman SN, Clark BA, Cantley L, Spokes K, Rosen S, Brezis M, Epstein FH. Effects of ioversol versus iothalamate on endothelin release and radiocontrast nephropathy. Invest Radiol 1993; 28: 313.
Rockoff SD, Brasch RC, Kuhn C, Charplyvy M. Contrast media as histamine liberators. I. Mast-cell histamine release in vitro by sodium salts of contrast media. Invest Radiol 1970; 5: 503.
Lasser EC. A general and personal perspective on contrast material research. Invest Radiol 1988; 23 [Suppl 1]: S71.
Baxter A, Lazarus SC, Brasch RC. In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media. Invest Radiol 1993; 4: 308.
Galli SJ. New concepts about the mast cell. N Engl J Med 1993; 328: 257.
de Paulis A, Marinò I, Ciccarelli A, de Crescenzo G, Concardi M, Verga L, Arbustini E, Marone G. Human synovial mast cells. I. Ultrastructure in situ and in vivo immunologic characterization. Arthritis Rheum 1996; 39: 1222.
Stellato C, Paulis A de, Cirillo R, Mastronardi P, Mazzarella B, Marone G. Heterogeneity of human mast cells and basophils in response to muscle relaxants. Anesthesiology 1991; 74: 1078.
Stellato C, Cirillo R, Paulis A de, Casolaro V, Patella V, Mastronardi P, Mazzarella B, Marone G. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. Anesthesiology 1992; 77: 932.
Patella V, Marinò I, Lamparter B, Arbustini E, Adt M, Marone G. Human heart mast cells, Ioslation, purification, ultrastructure, and immunologic characterization. J Immunol 1995; 154: 2855.
Ring J, Simon RA, Arroyave CM. Increased in vitro histamine release by radiographic contrast media in patients with history of incompatibility. Clin Exp Immunol 1978; 34: 302.
Rice MC, Lieberman P, Siegle RL, Mason J. In vitro histamine release induced by radiocontrast media and various chemical analogs in reactor and control subjects. J Allergy Clin Immunol 1983; 72: 180.
Lang DM, Alpern MB, Visintainer PF, Smith ST. Gender risk for anaphylactoid reaction to radiographic contrast media. J Allergy Clin Immunol 1995; 95: 813.
Assem ESK, Bray K. The release of histamine from human basophils by radiological contrast agents. Br J Radiol 1983; 56: 647.
Robertson PW, Frewin DB, Robertson AR, Mahar LJ, Jonsson JR. Plasma histamine levels following administration of radiographic contrast media. Br J Radiol 1985; 58: 1047.
Younger RE, Herrod HG, Lieberman PL, Trouy RL, Crawford LV. Characteristics of diatrizoate-induced basophil histamine release. J Allergy Clin Immunol 1986; 77: 94.
Amon EU, Ennis M, Schnabel M, Schneider C, Lorenz W. Radiographic contrast media-induced histamine release: a comparative study with mast cells from different species. Agents Actions 1989; 27: 104.
Amon EU, Ennis M, Lorenz W, Schnabel M, Schneider C. Histamine release induced by radiographic contrast media. Comparison between pulmonary and peritoneal mast cells derived from normotensive and spontaneously hypertensive rats. Int Arch Allergy Appl Immunol 1990; 92: 203.
Ennis M, Lorenz W, Schmal A, Dombrowski H. Histamine release and pseudoallergic reactions induced by radiographic contrast media: Comparison of Angiographin®, Hexabrix® and Telebrix® using an in vivo canine model. Agents Actions 1990; 30: 81.
Ennis M, Lorenz W, Nehring E, Schneider C. In vitro and in vivo studies of radiographic contrast media-induced histamine release in pigs. Agents Actions 1991; 33: 26.
Akagi M, Tasaka K. Comparative study of the adverse effects of various radiographic contrast media, including ioversol, a new low-osmolarity medium. I. Histamine release. Methods Find Exp Clin Pharmacol 1991; 13: 377.
Olin T. Adverse reactions to intravascularly administered contrast media. Acta Radiol 1986; 27: 257.
Vigorito C, Russo P, Picotti GB, Chiariello M, Poto S, Marone G. Effects of histamine infusion in man. J Cardiovasc Pharmacol 1983; 5: 531.
Vigorito C, Poto S, Picotti GB, Triggiani M, Marone G. Effects of activation of the H1 receptor on coronary hemodynamics in man. Circulation 1986; 73: 1175.
Marone G, Giordano A, Cirillo R, Triggiani M, Vigorito C. Cardiovascular and metabolic effects of peptide leukotrienes in man. Ann NY Acad Sci 1988; 524: 321.
Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989; 83: 1551.
Schwartz LB, Kawahara MS, Hugli TE, Vik D, Fearon DT, Austen KF. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J Immunol 1983; 130: 1891.
Arroyave CM, Schatz M, Simon RA. Activation of the complement system by radiographic contrast media: studies in vivo and in vitro. J Allergy Clin Immunol 1979; 63: 276.
Cogen FC, Norman ME, Dunksy E, Hirshfeld J, Zweiman B. Histamine release and complement changes following injection of contrast media in humans. J Allergy Clin Immunol 1979; 64: 299.
Westaby S, Dawson P, Turner MW, Pridie RB. Angiography and complement activation. Evidence for generation of C3a anaphylatoxin by intravascular contrast agents. Cardiovasc Res 1985; 19: 85.
Gardinali M, Cicardi M, Frangi D, Franzinelli M, Gattoni F, Uslenghi C, Agostoni A. In vivo study of the complement system during infusion of radiographic contrast media. J Allergy Clin Immunol 1986; 77: 690.
Patella V, Crescenzo G de, Ciccarelli A, Marinò I, Adt M, Marone G. Human heart mast cells: a definitive case of mast cell heterogencity. Int Arch Allergy Immunol 1995; 106: 386.
Stellato C, Paulis A de, Ciccarelli A, Cirillo R, Patella V, Casolaro V, Marone G. Anti-inflammatory effect of cyclosporin A on human skin mast cells. J Invest Dermatol 1992; 98: 800.
Boer M de, Roos D. Metabolic comparison between basophils and other leukocytes from human blood. J Immunol 1986; 136: 3447.
Casolaro V, Galeone D, Giacummo A, Sanduzzi A, Melillo G, Marone G. Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood lung parenchyma, and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 1989; 139: 1375.
Patella V, Casolaro V, Ciccarelli A, Pettit GR, Columbo M, Marone G. The antineoplastic bryostatins affect differently human basophils and mast cells. Blood 1995; 85: 1272.
Columbo M, Bochner BS, Marone G. Human skin mast cells express functional β1 integrins that mediate adhesion to extracellular matrix proteins. J Immunol 1995; 154: 6058.
Snedecor GW, Cochran WG. Statistical methods. Ames: The lowa State University Press, 1980.
Tennant JR. Evaluation of trypan blue for determination of cell viability. Transplantation 1964; 2: 685.
Paulis A de, Cirillo R, Ciccarelli A, Condorelli M, Marone G. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human FcεRI+ cells. J Immunol 1991; 146: 2374.
Findlay SR, Dvorak AM, Kagey-Sobotka A, Lichtenstein LM. Hyperosmolar triggering of histamine release from human basophils. J Clin Invest 1981; 67: 1604.
Eggleston PA, Kagey-Sobotka A, Schleimer RP, Lichtenstein LM. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am Rev Respir Dis 1984; 130: 86.
Eggleston PA, Kagey-Sobotka A, Lichtenstein LM. A comparison of the osmotic activation of basophils and human lung mast cells. Am Rev Respir Dis 1987; 135: 1043.
Schwartz LB, Metcalfe DD, Miller JS, Earle H, Sullivan T. Tryptase levels as an indication of mast cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987; 316: 1622.
Yocum MW, Heller AM, Abels RI. Efficacy of intravenous pretesting and antihistamine prophylaxis in radiocontrast mediasensitive patients. J Allergy Clin Immunol 1978; 62: 309.
Greenberger PA, Patterson R, Simon R, Lieberman P, Wallace W. Pretreatment of high-risk patients requiring radiographic contrast media studies. J Allergy Clin Immunol 1981; 67: 185.
Druck MN, Johnstone DE, Staniloff H, McLaughlin PR. Coronary artery spasm as a manifestation of anaphylactoid reaction to iodinated radiocontrast materials. Can Med Assoc J 1981; 125: 1133.
Gerber KH, Higgens CB, Yuh Y-S, Koziol JA. Regional myocardial hemodynamic and metabolic effects of ionic and nonionic contrast media in normal and ischemic states. Circulation 1982; 65: 1307.
Bush WH, Swanson D. Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. Aust J Radiol 199; 157: 1153.
Kalsner S, Richards R. Coronary arteries of cardiac patients are hyperreactive and contain stores of amines: a mechanism for coronary spasm. Science 1984; 223: 1435.
Kaartinen M, Penttilä A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 1994; 90: 1669.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Genovese, A., Stellato, C., Patella, V. et al. Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue. Int J Clin Lab Res 26, 192–198 (1996). https://doi.org/10.1007/BF02592981
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02592981